These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304 [TBL] [Abstract][Full Text] [Related]
9. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al. Romano AG; Quinn JL; Li L; Dave KD; Schindler EA; Aloyo VJ; Harvey JA Psychopharmacology (Berl); 2010 Oct; 212(3):441-8. PubMed ID: 20827462 [TBL] [Abstract][Full Text] [Related]
10. An animal model of schizophrenia based on chronic LSD administration: old idea, new results. Marona-Lewicka D; Nichols CD; Nichols DE Neuropharmacology; 2011 Sep; 61(3):503-12. PubMed ID: 21352832 [TBL] [Abstract][Full Text] [Related]
11. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Halberstadt AL; Geyer MA Neuropharmacology; 2011 Sep; 61(3):364-81. PubMed ID: 21256140 [TBL] [Abstract][Full Text] [Related]
12. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors. Gresch PJ; Strickland LV; Sanders-Bush E Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572 [TBL] [Abstract][Full Text] [Related]
13. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex. Schindler EA; Harvey JA; Aloyo VJ Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701 [TBL] [Abstract][Full Text] [Related]
14. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites. Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973 [TBL] [Abstract][Full Text] [Related]
15. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221 [TBL] [Abstract][Full Text] [Related]
16. Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice. Moreno JL; Holloway T; Umali A; Rayannavar V; Sealfon SC; González-Maeso J Psychopharmacology (Berl); 2013 Jan; 225(1):217-26. PubMed ID: 22842765 [TBL] [Abstract][Full Text] [Related]
17. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Marona-Lewicka D; Nichols DE Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679 [TBL] [Abstract][Full Text] [Related]
18. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. Marek GJ; Aghajanian GK J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525 [TBL] [Abstract][Full Text] [Related]
19. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes. Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097 [TBL] [Abstract][Full Text] [Related]